Ipsen finalise l’acquisition de Kartos Therapeutics, renforçant son portefeuille d’oncologie en phase avancée – GlobeNewswire

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Δ